SummaryWe investigated the effects of magnesium sulphate on blood coagulation profiles using rotational thromboelastometry in gynaecological patients undergoing pelviscopic surgery. Patients were randomly allocated to the magnesium group (n = 20) or control group (n = 20). The magnesium group received magnesium sulphate (50 mg.kg )1 followed by continuous infusion of 15 mg.kg), whereas the control group received the same volume of isotonic saline according to the same methods. Mean (SD) postoperative serum magnesium levels were 1.58 (0.17) mmol.l )1 in the magnesium group compared with 0.98 (0.06) mmol.l )1 in the control group (p < 0.001). Postoperative clotting time, clot formation time, a-angle and maximum clot firmness of INTEM, and clot formation time, a-angle, and maximum clot firmness of EXTEM were significantly different between the two groups (p < 0.05). Intra-operative infusion of magnesium sulphate seems to attenuate postoperative hypercoagulability by maintaining magnesium levels at the upper limit of the normal range. Hypercoagulability following haemodilution with crystalloid was first reported in the 1950s [4,5], and several investigators subsequently confirmed haemodilutioninduced hypercoagulability in vitro [6][7][8] and in vivo [9,10]. However, fluid administration is inevitably required during the peri-operative period, and major surgery and peri-operative stress responses can activate the coagulation cascade [11,12]. In contrast, Ravn et al. reported that intravenous magnesium had no effect on coagulation factors or fibrinolytic activity [13]. Serebruany et al. [14] reported that platelet activation and hypercoagulable changes in coagulation factors were observed after magnesium infusion in healthy volunteers.As mentioned above, clinical outcomes are still inconclusive and questions remain regarding how magnesium affects blood coagulability. It is important